SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets

[1]  I. Koutlas,et al.  Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations , 2021, The American journal of surgical pathology.

[2]  J. Bishop,et al.  Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33–RET fusions and BRAF V600E mutations , 2020, Histopathology.

[3]  J. Vondrák,et al.  Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts , 2020, The American journal of surgical pathology.

[4]  A. Agaimy,et al.  Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions , 2020, The American journal of surgical pathology.

[5]  Youngwook Kim,et al.  Integrative genomic analysis of salivary duct carcinoma , 2020, Scientific Reports.

[6]  B. Wan,et al.  Abstract 38: Large-scale study of NTRK fusions in Chinese solid tumors and using next generation sequencing: A multicenter study , 2020 .

[7]  M. Hyrcza,et al.  Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion , 2020, The American journal of surgical pathology.

[8]  J. Bishop,et al.  Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel STRN-ALK Fusion , 2020, Head and Neck Pathology.

[9]  G. Stenman,et al.  Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB , 2020, Genes, chromosomes & cancer.

[10]  J. S. Nix,et al.  Navigating small biopsies of salivary gland tumors: a pattern-based approach. , 2020, Journal of the American Society of Cytopathology.

[11]  J. Rao,et al.  NOR-1 Distinguishes Acinic Cell Carcinoma from Its Mimics on Fine Needle Aspiration Biopsy Specimens. , 2020, Human pathology.

[12]  R. Franco,et al.  NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine , 2020, International journal of molecular sciences.

[13]  Y. Tada,et al.  Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma , 2020, Histopathology.

[14]  B. Dickson,et al.  Salivary Gland Cancer in the Era of Routine Next-Generation Sequencing , 2020, Head and Neck Pathology.

[15]  J. Reis-Filho,et al.  Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG) , 2020, The American journal of surgical pathology.

[16]  T. Tsuzuki,et al.  Histopathological evaluation of minor salivary gland papillary–cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm , 2020, Histopathology.

[17]  A. Drilon,et al.  Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. , 2019, The Lancet. Oncology.

[18]  M. Couce,et al.  Sclerosing Polycystic “Adenosis” of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma , 2019, Head and Neck Pathology.

[19]  N. Rupp,et al.  NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors , 2019, The American journal of surgical pathology.

[20]  M. Ladanyi,et al.  ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. , 2019 .

[21]  R. Eils,et al.  Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands , 2019, The American journal of surgical pathology.

[22]  J. Bishop,et al.  Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes , 2019, Head and Neck Pathology.

[23]  J. Reis-Filho,et al.  Histologic Spectrum of Polymorphous Adenocarcinoma of the Salivary Gland Harbor Genetic Alterations Affecting PRKD Genes , 2019, Modern Pathology.

[24]  N. Rupp,et al.  New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation , 2019, Head and Neck Pathology.

[25]  K. Sakurai,et al.  Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum , 2019, The American journal of surgical pathology.

[26]  B. Dickson,et al.  Metastasizing Pleomorphic Adenoma , 2019, The American journal of surgical pathology.

[27]  B. Dickson,et al.  Microsecretory Adenocarcinoma , 2019, The American journal of surgical pathology.

[28]  Simion I. Chiosea,et al.  The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland , 2019, The American journal of surgical pathology.

[29]  Z. Baloch,et al.  Salivary Gland Fine Needle Aspiration and Introduction of the Milan Reporting System , 2019, Advances in anatomic pathology.

[30]  C. Antonescu,et al.  Adamantinoma-like Ewing Sarcoma of the Salivary Glands: A Newly Recognized Mimicker of Basaloid Salivary Carcinomas , 2019, The American journal of surgical pathology.

[31]  R. Eils,et al.  Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands , 2019, Nature Communications.

[32]  D. E. da Cruz Perez,et al.  KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features , 2019, Modern Pathology.

[33]  Tsuyoshi Saito,et al.  Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features , 2018, Histopathology.

[34]  P. Homøe,et al.  Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma , 2018, Acta ophthalmologica.

[35]  M. Leader,et al.  Molecular Profiling of Hyalinizing Clear Cell Carcinomas Revealed a Subset of Tumors Harboring a Novel EWSR1-CREM Fusion: Report of 3 Cases , 2018, The American journal of surgical pathology.

[36]  H. Iro,et al.  Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys Mutation , 2018, The American journal of surgical pathology.

[37]  Y. Ning,et al.  Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. , 2018, The American journal of surgical pathology.

[38]  A. Eijkelenboom,et al.  Clear Cell Odontogenic Carcinoma: Occurrence of EWSR1-CREB1 as Alternative Fusion Gene to EWSR1-ATF1 , 2018, Head and Neck Pathology.

[39]  C. Fisher,et al.  NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas , 2018, The American journal of surgical pathology.

[40]  I. Burger,et al.  New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation , 2018, Virchows Archiv.

[41]  R. de Bree,et al.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update , 2018, European Archives of Oto-Rhino-Laryngology.

[42]  Funda Meric-Bernstam,et al.  Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.

[43]  K. Takeuchi,et al.  MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts , 2018, Modern Pathology.

[44]  N. Rupp,et al.  Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases , 2018, The American journal of surgical pathology.

[45]  J. Bishop,et al.  The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas , 2018, The American journal of surgical pathology.

[46]  Wen-Chih Huang,et al.  CTNNB1 mutations in basal cell adenoma of the salivary gland. , 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

[47]  Simion I. Chiosea,et al.  Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases , 2017, The American journal of surgical pathology.

[48]  Simion I. Chiosea,et al.  Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland , 2017, The American journal of surgical pathology.

[49]  G. Rath,et al.  Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases , 2017, European Archives of Oto-Rhino-Laryngology.

[50]  Simion I. Chiosea,et al.  The HTN 3-MSANTD 3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland , 2018 .

[51]  C. Antonescu,et al.  Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions , 2017, Nature Communications.

[52]  L. Sholl,et al.  Distinctive Patterns of CTNNB1 (&bgr;-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma , 2016, The American journal of surgical pathology.

[53]  Jonathan R. Clark,et al.  Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations , 2016, Head & neck.

[54]  P. Speight,et al.  Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[55]  Huining Kang,et al.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. , 2016, Cancer discovery.

[56]  I. Leivo.  Sinonasal Adenocarcinoma: Update on Classification, Immunophenotype and Molecular Features , 2016, Head and Neck Pathology.

[57]  H. Makarenkova,et al.  Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair , 2015, Current Molecular Biology Reports.

[58]  C. Antonescu,et al.  Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. , 2015, Human pathology.

[59]  Simion I. Chiosea,et al.  Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin , 2014, Genes, chromosomes & cancer.

[60]  Simion I. Chiosea,et al.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands , 2014, Nature Genetics.

[61]  C. Antonescu,et al.  NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. , 2014, Cancer discovery.

[62]  R. West,et al.  Identification of recurrent SMO and BRAF mutations in ameloblastomas , 2014, Nature Genetics.

[63]  R. Seethala,et al.  Secretory Myoepithelial Carcinoma: A Histologic and Molecular Survey and a Proposed Nomenclature for Mucin Producing Signet Ring Tumors , 2014, Head and Neck Pathology.

[64]  H. Okano,et al.  SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis , 2013, Modern Pathology.

[65]  M. Michal,et al.  Cribriform Adenocarcinoma of the Tongue and Minor Salivary Glands: A Review , 2013, Head and Neck Pathology.

[66]  Holger Moch,et al.  KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics. , 2013, The Journal of molecular diagnostics : JMD.

[67]  Simion I. Chiosea,et al.  DOG1: a novel marker of salivary acinar and intercalated duct differentiation , 2012, Modern Pathology.

[68]  A. B. Smith,et al.  Sclerosing Polycystic Adenosis , 2012, Head and Neck Pathology.

[69]  C. Antonescu,et al.  EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland , 2011, Genes, chromosomes & cancer.

[70]  B. Perez-Ordonez,et al.  Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity , 2010, The American journal of surgical pathology.

[71]  Y. Hasegawa,et al.  Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinoma , 2009, Modern Pathology.

[72]  R. Seethala,et al.  Oncocytic Mucoepidermoid Carcinoma: Clinicopathologic Description in a Series of 12 Cases , 2009, The American journal of surgical pathology.

[73]  R. Seethala.  An Update on Grading of Salivary Gland Carcinomas , 2009, Head and neck pathology.

[74]  F. Persson,et al.  High‐resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2 , 2009, Genes, chromosomes & cancer.

[75]  K. Riden,et al.  CLASSIFICATION OF HEAD AND NECK TUMOURS , 1998 .